908 Devices (MASS) Return on Invested Capital (2024 - 2025)

908 Devices' (MASS) quarterly Return on Invested Capital came in at 0.01% in Q4 2025, up 63.97% on a QoQ basis from 0.03% in Q3 2025.

908 Devices (MASS) Return on Invested Capital (2024 - 2025) Analysis & Trends

908 Devices (MASS) has 2 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2025.

On a quarterly basis, Return on Invested Capital changed N/A year-over-year to 0.01% in Q4 2025; TTM through Dec 2025 was 0.01%, a N/A change from a year earlier, with the FY2023 full-year figure at 0.05%, changed N/A from the prior year.
Return on Invested Capital for Q4 2025 stood at 0.01%, up from 0.03% in the prior quarter.
Over the last five years, Return on Invested Capital for MASS reached as high as 0.01% in Q4 2025 and fell as low as 0.58% in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	0.01%
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	0.01%
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	0.01%
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	0.00%
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	0.00%
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	908 Devices	261.78 Mn	150.04 Mn	6.88 Mn	-

Download Data